NYSE: EBS
Emergent Biosolutions Inc Stock Ownership - Who owns Emergent Biosolutions?

Insider buying vs selling

Have Emergent Biosolutions Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Coleen GlessnerEVP Quality Ethics and CPL2025-06-081,249$6.63
$8.28kSell
Richard S. LindahlEVP Chief Financial Officer2025-06-082,733$6.63
$18.12kSell
William HartzelSVP Bioservices2025-06-081,167$6.63
$7.74kSell
Paul Anthony WilliamsSVP Products Business2025-06-08464$6.63
$3.08kSell
Keith KatkinDirector2025-05-237,844$6.30
$49.42kSell
Joseph C. PapaPresident and CEO2025-05-1360,000$5.83
$349.80kBuy
William HartzelSVP Bioservices2025-04-07561$4.44
$2.49kSell
Coleen GlessnerEVP Quality Ethics and CPL2025-04-07480$4.44
$2.13kSell
Neal Franklin FowlerDirector2025-03-1235,000$5.83
$204.05kSell
Kathryn C. ZoonDirector2025-03-1210,000$5.73
$57.30kSell

1 of 3

EBS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EBS insiders and whales buy or sell their stock.

EBS Shareholders

What type of owners hold Emergent Biosolutions Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri47.41%25,733,310$160.06MInsider
Intervac LLC8.00%4,344,250$27.02MInsider
Vanguard Group Inc5.92%3,214,003$19.99MInstitution
Millennium Management LLC4.61%2,502,488$15.57MInstitution
American Century Companies Inc4.23%2,297,621$14.29MInstitution
Biopharm LLC4.17%2,265,043$14.09MInsider
Robert Calvin Myers3.56%1,934,849$12.03MInsider
Blackrock Inc3.38%1,835,562$11.42MInstitution
State Street Corp3.15%1,710,749$10.64MInstitution
Biovac LLC2.95%1,599,155$9.95MInsider

1 of 3

EBS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EBS41.97%58.03%Net SellingNet Buying
AQST44.55%7.79%Net SellingNet Selling
TLRY9.14%1.85%Net BuyingNet Buying
ETON52.66%32.38%Net BuyingNet Selling
TKNO11.45%63.97%Net Buying

Emergent Biosolutions Stock Ownership FAQ

Who owns Emergent Biosolutions?

Emergent Biosolutions (NYSE: EBS) is owned by 66.68% institutional shareholders, 92.18% Emergent Biosolutions insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Emergent Biosolutions shareholder, owning 25.73M shares representing 47.41% of the company. Fuad Elhibri's Emergent Biosolutions shares are currently valued at $160.06M.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.